VANCOUVER, BC, Canada, March 29, 2023 – Aspect Biosystems announced today that CEO Tamer Mohamed will present at the annual Cell & Gene Meeting on the Med to be held April 12-14, 2023 in Barcelona, Spain and livestreamed globally.
Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Med is a two-day conference featuring more than 60 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies, as well as over 100 panelists and featured speakers.
The following are specific details regarding Aspect Biosystems’ presentation at the conference:
|Event||2023 Cell & Gene Meeting on the Med|
|Date||Wednesday, April 12, 2023|
|Location||Hotel Arts Barcelona|
Barcelona, 08005 Spain
Virtual attendance is available which includes a livestream of Aspect Biosystems’ presentation and the ability to view all conference sessions on-demand.
Please visit https://meetingonthemed.com/ for full information including registration.
About Aspect Biosystems
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases. Learn more at www.aspectbiosystems.com.